US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) ニュース

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/01	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/31	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/31	20 : 00	GlobeNewswire Inc.	Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/31	19 : 01	IH Market News	US Index Futures Up Ahead of Fed Decision; Oil Prices Surge Amid Middle East Tensions	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/25	14 : 30	Business Wire	Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/18	21 : 30	Business Wire	Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/07/03	07 : 00	Business Wire	Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/29	07 : 34	Business Wire	Les nouvelles données portant sur AJOVY® (fremanezumab) dans la prévention de la migraine remettent en question les pauses thérapeutiques	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/29	04 : 41	Business Wire	Neue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention stellen Behandlungspausen in Frage	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/29	00 : 30	Business Wire	New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/25	21 : 00	Business Wire	Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/24	22 : 50	Business Wire	Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	21 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	21 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/17	20 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/14	20 : 21	IH Market News	Adobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and More	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/05	05 : 05	Business Wire	Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/02	03 : 25	Business Wire	New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/06/02	03 : 20	Business Wire	Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/30	07 : 38	Business Wire	Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/21	09 : 25	GlobeNewswire Inc.	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/21	09 : 25	Business Wire	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/15	21 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2024/05/15	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd

Showing the most relevant articles for your search:NYSE:TEVA

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

Gold vs US Dollar

Energy Select Sector SPDR

Deutsche Telekom (QX)

BNP Paribas (QX)

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約